Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCano, Amanda
dc.contributor.authorFonseca Hernandez, Elena
dc.contributor.authorEttcheto, Miren
dc.contributor.authorSánchez-López, Elena
dc.contributor.authorde Rojas, Itziar
dc.contributor.authorAlonso-Lana, Silvia
dc.contributor.authorToledo Argany, Manuel
dc.date.accessioned2022-05-05T12:49:38Z
dc.date.available2022-05-05T12:49:38Z
dc.date.issued2021-10
dc.identifier.citationCano A, Fonseca E, Ettcheto M, Sánchez-López E, Rojas I de, Alonso-Lana S, et al. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals. 2021 Oct;14(10):1057.
dc.identifier.issn1424-8247
dc.identifier.urihttps://hdl.handle.net/11351/7488
dc.descriptionMalaltia d'Alzheimer; Malaltia de Huntington; Malaltia de Parkinson
dc.description.sponsorshipA.C. acknowledges the support of the Spanish Ministry of Science, Innovation and Universities under the grant Juan de la Cierva (FJC2018-036012-I). Authors acknowledge the support of the Instituto de Salud Carlos III (ISCIII) Acción Estratégica en Salud, integrated into the Spanish National R+D+I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER “Una manera de hacer Europa”) grant PI17/01474 awarded to M.B. Boada, grant PI19/00335 awarded to M.M. and the European Social Fund (ESF “Investing in your future”) for the Sara Borrell Contract (CD19/00232) to SA-L; M.E. acknowledges the support of the Spanish Ministry of Economy and Competitiveness under the project SAF2017-84283-R, and CIBERNED under project CB06/05/0024. E.B.S. acknowledges the support of the Portuguese Science and Technology Foundation (FCT) for the strategic fund (UIDB/04469/2020). A.R. acknowledges the support of CIBERNED (Instituto de Salud Carlos III (ISCIII)), the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, ADAPTED Grant Nº 115975, from EXIT project, EU Euronanomed3 Program JCT2017 Grant Nº AC17/00100, from PREADAPT project. Joint Program for Neurodegenerative Diseases (JPND) Grant No. AC19/00097, and from grants PI13/02434, PI16/01861 BA19/00020, and PI19/01301. Acción Estratégica en Salud, integrated in the Spanish National RCDCI Plan and financed by Instituto de Salud Carlos III (ISCIII)- Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de Hacer Europa”), by Fundación bancaria “La Caixa” and Grífols SA (GR@ACE project).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesPharmaceuticals;14(10)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectSistema nerviós - Degeneració - Tractament
dc.subjectEpilèpsia
dc.subjectAnticonvulsius - Ús terapèutic
dc.subject.meshNeurodegenerative Diseases
dc.subject.mesh/drug therapy
dc.subject.meshEpilepsy
dc.subject.meshAnticonvulsants
dc.titleEpilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/ph14101057
dc.subject.decsenfermedades neurodegenerativas
dc.subject.decs/farmacoterapia
dc.subject.decsepilepsia
dc.subject.decsanticonvulsivantes
dc.relation.publishversionhttps://doi.org/10.3390/ph14101057
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Cano A] Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain. Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Nanoscience and Nanotechnology (IN2UB), 08028 Barcelona, Spain. [Fonseca E, Toledo M] Unitat d’Epilèpsia, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Estat Epilèptic i Convulsions Agudes, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Ettcheto M] Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Neurosciences (UBNeuro), University of Barcelona, 08007 Barcelona, Spain. [Sánchez-López E] Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Nanoscience and Nanotechnology (IN2UB), 08028 Barcelona, Spain. [de Rojas I] Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain. Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. [Alonso-Lana S] Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain
dc.identifier.pmid34681281
dc.identifier.wos000716873000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple